Concepedia

Dawn K. Slifka

DK

3

Publications

71

Citations

3

H-Index

2016

Active since

Affiliations

Najít Technologies (United States)(Current)

Oregon Health & Science University

Oregon National Primate Research Center

Dawn K. Slifka is an author at Najít Technologies (United States) specializing in vaccine development, vaccination, and infection control.

Top concepts

Publications per year

2016–2022

3

Publications

3

An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults

Christopher W. Woods, Ana M. Sánchez, Geeta K. Swamy et al. · Vaccine · 2019 · 31 citations · Full text

Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine

Elizabeth A. Poore, Dawn K. Slifka, Hans-Peter Raué et al. · Vaccine · 2016 · 21 citations · Full text

, , +7

Development of a next-generation chikungunya virus vaccine based on the HydroVax platform

Dawn K. Slifka, Hans-Peter Raué, Whitney C. Weber et al. · PLoS Pathogens · 2022 · 19 citations · Full text

Rows per page

1–3 of 3